Literature DB >> 15772427

Metabolic kinetics of pulmonary surfactant in newborn infants using endogenous stable isotope techniques.

Kajsa Bohlin1, Bruce W Patterson, Kimberly L Spence, Assaad Merchak, James C G Zozobrado, Luc J I Zimmermann, Virgilio P Carnielli, Aaron Hamvas.   

Abstract

We compared kinetic indices of pulmonary surfactant metabolism in premature infants (n = 41) with respect to i) tracer ([1-(13)C1]acetate, [U-(13)C6]glucose, and [1,2,3,4-(13)C4] palmitate), ii) phospholipid (PL) pool (total PLs or disaturated PLs), or iii) instrumentation [gas chromatography/mass spectrometry (GC/MS) or GC-combustion-isotope ratio mass spectometry (GC-C-IRMS)]. Tracer incorporation was measured in PLs extracted from serial tracheal aspirates after a 24 h tracer infusion. The fractional catabolic rate (FCR), representing the total fractional turnover from all sources of surfactant production, was independent of tracer. The fractional synthesis rate of surfactant PL from plasma palmitate was significantly higher than that from palmitate synthesized de novo from acetate, and these two sources of palmitate together accounted for only half of the total surfactant production in preterm infants. [U-(13)C6]glucose showed significant recycling of the (13)C label in intermediary metabolism, distinguishable by GC-MS but not by GC-C-IRMS, resulting in a slower apparent FCR when GC-C-IRMS was used. The extracted PL pool did not affect the surfactant metabolic indices. We suggest that FCR should be used as a primary measure of surfactant turnover kinetics and that tracers labeling both de novo synthesis (acetate and glucose) and preformed pathways (plasma palmitate) can be used to partition the fractional contribution of each pathway to total production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772427     DOI: 10.1194/jlr.M400481-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

1.  Measurement of human surfactant protein-B turnover in vivo from tracheal aspirates using targeted proteomics.

Authors:  Daniela M Tomazela; Bruce W Patterson; Elizabeth Hanson; Kimberly L Spence; Tiffany B Kanion; David H Salinger; Paolo Vicini; Hugh Barret; Hillary B Heins; F Sessions Cole; Aaron Hamvas; Michael J MacCoss
Journal:  Anal Chem       Date:  2010-03-15       Impact factor: 6.986

Review 2.  An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease.

Authors:  Paul O Nkadi; T Allen Merritt; De-Ann M Pillers
Journal:  Mol Genet Metab       Date:  2009-02-04       Impact factor: 4.797

3.  Role of fat body lipogenesis in protection against the effects of caloric overload in Drosophila.

Authors:  Laura Palanker Musselman; Jill L Fink; Prasanna Venkatesh Ramachandran; Bruce W Patterson; Adewole L Okunade; Ezekiel Maier; Michael R Brent; John Turk; Thomas J Baranski
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

4.  Metabolic precursors of surfactant disaturated-phosphatidylcholine in preterms with respiratory distress.

Authors:  Paola E Cogo; Carlo Ori; Manuela Simonato; Giovanna Verlato; Ilena Isak; Aaron Hamvas; Virgilio P Carnielli
Journal:  J Lipid Res       Date:  2009-05-27       Impact factor: 5.922

Review 5.  Current technology in the diagnosis of developmentally related lung disorders.

Authors:  Aaron Hamvas
Journal:  Neonatology       Date:  2012-06-01       Impact factor: 4.035

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.